Acute lung injury and acute respiratory distress syndrome

Indian Journal of Pediatrics

Volumn 71, Issue 8, 2004, Pages 743-750

  Vasudevan, Anil ^a   Lodha, Rakesh ^a   Kabra, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

ALI; ARDS; Mechanical ventilation

Indexed keywords

ALMITRINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; HYDRALAZINE; IBUPROFEN; INDOMETACIN; KETOCONAZOLE; LISOFYLLINE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN E1; SEDATIVE AGENT; SURFACTANT; VASODILATOR AGENT;

ACUTE DISEASE; ANALGESIA; ARTIFICIAL VENTILATION; BODY POSTURE; CHILD; CHILD HOSPITALIZATION; CHILDHOOD MORTALITY; CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CRITICAL ILLNESS; DISEASE COURSE; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; EXUDATE; HIGH FREQUENCY VENTILATION; HUMAN; INCIDENCE; INFLAMMATION; INTENSIVE CARE UNIT; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG ENDOTHELIUM; LUNG FIBROSIS; LUNG GAS EXCHANGE; LUNG INJURY; LUNG SURGERY; NUTRITION; OUTCOMES RESEARCH; PATHOGENESIS; PATHOLOGY; PATIENT POSITIONING; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; PSYCHOSOCIAL CARE; RESPIRATORY DISTRESS SYNDROME; SEDATION; TIDAL VOLUME; VENTILATOR;

EID: 4544234662     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02730667     Document Type: Conference Paper

References (77)

1. Ashbaug DG, Bigelow DB, Petty TL, Levine BE. ARDS in adults. Lancet 1967; 2: 319-323.
2. Murray JF, Matthay MA, Luce JM et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-723.
3. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-829.
4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
5. Amato MB, Barbas CS, Medeiros DM, Magoldi RB, Schettino GP et al. Effect of a protective ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338: 347-354.
6. Hudson LD, Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest 1999; 116: 74S-82S.
7. Pfenninger J, Gerber A, Tschappeler H, Zimmermann A. Adult respiratory distress syndrome. J Pediatr 1982; 101: 352-357.
8. Lyrene RK, Trough WE. Adult respiratory distress syndrome in a pediatric intensive care unit. Predisposing conditions clinical course and outcome. Pediatrics. 1991; 67: 790-795.
9. Nussbaum E. Adult type respiratory distress syndrome in children. Clin Pediatr 1983; 22: 401-406.
10. Lodha R, Kabra SK, Pandey RM. Acute respiratory distress syndrome: experience at a tertiary care hospital. Indian Pediatr 2001; 38: 1154-1159.
11. Tan Hoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: Analysis of 1993 National Mortality Follow Back Study. Chest 2001; 119: 1179-1184.
12. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved Survival of patients with acute respiratory distress syndrome (ARDS); 1983-1993. JAMA 1995; 273: 306-309.
13. Davis SL, Furman DP, Costarino AT Jr. Adult respiratory distress syndrome in children, associated disease, clinical course and predictors of death. J Pediatr 1993; 123: 306-309.
14. Moss N, Goodman PL, Heining M et al. Establishing the relative accuracy of three new definitions of the adult respiratory distress sydnrome. Crit Care Med 1995; 23: 1629-1637.
15. Fowler AA, Hamman RF, Good JT et al. Adult respiratory distress syndrome: risk with common predisposition. Ann Intern Med 1983; 98: 593-597.
16. Hudson LD, Milberg JA, Anardi D et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 293-301.
17. Doyle RL, Szaflarski N, Modni GW, Weiner-Kronish JP, Matthay MA. Identification of patients with acute lung injury: predictors of mortality. Am J Respir Crit Care Med 1995; 152: 1818-1824.
18. Keenan HT, Bratton SL, Martin LD, Crawford SW, Weiss NS. Outcome of children who require mechanical ventilatory support after bone marrow transplantation. Crit Care Med 2000; 28: 830-835.
19. Chestnutt AN, Matthay MA, Tibayan FA et al. Early detection of type III procollagen peptide in acute lung injury. Pathogenic and prognostic significance. Am J Respir Crit Care Med 1997; 156: 840-845.
20. Marshall RP, Bellingan GJ, Gunn S et al. Fibro proliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000; 162: 1783-1788.
21. Weiland JE, Davis WB, Holter JF et al. Lung neutrophils in the adult respiratory distress syndrome-Clinical and pathological significance. Am Rev Respir Dis 1986; 133: 218-225.
22. Coker RK, Laurent GJ. Pulmonary fibrosis: Cytokines in the balance. Eur Respir J 1998; 11: 1218-1221.
23. Lee CT, Fein AM, Lippmann M et al. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 1981; 304: 192-196.
24. Zhang H, Slutsky AS, Vincent JL. Oxygen free radicals in ARDS, septic shock and organ dysfunction. Intensive Care Med 2000; 26: 474-476.
25. Amstrong L, Millar AB. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. Thorax 1997; 52: 442-446.
26. Chua F, Dunsmore SE, Mutsaers SE et al. Characterization of the response to mice deficient in neutrophil elastase or cathepsin G to bleomycin. Am J Respir Crit Care Med 2001; 163: 231.
27. Donnelly SC, Haslett C, Dransfield I et al. Role of selectin in development of adult respiratory distress syndrome. Lancet 1994; 344: 215-219.
28. Braude S, Apperley J, Kransz T et al. Adult respiratory distress syndrome after allogenic bone-marrow transplantation; evidence for a netrophil independent mechanisms. Lancet 1985; 1: 1239-1242.
29. Pugin J, Ricon B, Steinberg KP et al. Pro inflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for IL-1. Am J Respir Crit Care Med 1996; 153: 1850-1856.
30. Donnelly SC, Srtieter RM, Kunkel SL et al. Interleukin 8 and development of adult respiratory distress syndrome in at risk patient groups. Lancet 1993; 341: 643-647.
31. Haddad IY, Pataki G, Hu P et al. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994; 94: 2407-2413.
32. Matute-Bello G, Liles WC, Radella F et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 156: 1969-1977.
33. Druml W, Steltzer H, Waldhansl W et al. Endothelin in adult respiratory distress syndrome. Am Res Respir Dis 1993; 148: 1169-1173.
34. Baudouin SV. Surfactant medication for acute respiratory distress syndrome. Thorax 1997; 52: S9-S19.
35. Marshall R, Bellingan G, Laurent G. The acute respiratory distress syndrome. Fibrosis in the fast lane. Thorax 1998; 53: 815-817.
36. Khalil N, Greenberg AH. The role of TGF-? in pulmonary fibrosis. Ciba Found Symp 1991; 157: 194-207.
37. McHugh LG, Milberg JA, Whitcomb ME et al. Recovery of function in survivors of the acute of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150: 90-94.
38. Rotta AT, Kunrath CL, Wiryawan B. Management of the acute respiratory distress syndroem. J de Pediatria 2003; 79: S149-S160.
39. The Acute Respiratory Distress Syndrome Network (ARDSNet). Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
40. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodden RV, Lapinsky SE et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure and volume limited ventilation strategy group. N Engl J Med 1998; 338: 355-361.
41. Brochard L, Roudot TF, Roupie E, Delclaux C, Chastre J, Femandez-Mondejan E, et al. Tidal volume reduction for prevention of ventilator induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 1998; 158: 1831-1838.
42. Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hyper capnia in severe adult respiratory distress syndrome. Intensive Care Med 1990; 16: 372-377.
43. Carvalho CR, Barbas CS, Medeiros DM, Magaldi RB, Lorenzi FG, Kairalla RA et al. Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS. Am J Respir Crit Care Med 1997; 156: 1458-1466.
44. Slutsky AS. Lung injury caused by mechanical ventilation Chest 1999; 116 (Suppl1): 9-15.
45. Rotta AT, Gunnarsson B, Fuhrman BP, Hernan LJ, Steintrom BM. Comparison of lung protective ventilation strategies in a rabbit model of acute lung injury. Crit Care Med 2001; 29: 2176-2184.
46. Arnold JH, Hanson JH, Toro-Figuero LO, Gutierrez J, Berens RJ, Anglin DL. Prospective, randomised comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994; 22: 1530-1539.
47. Moganasundram S, Durward A, Tibby SM, Murdoch IA. High frequency oscillation in adolescents. Br J Anaesth 2002; 88: 708-711.
48. Arnold JH, Anas NG, Luckett P et al. High frequency oscillatory ventilation in pediatric respiratory failure: a multicenter experience. Crit Care Med 2000; 28: 3912-3919.
49. Hirschl RB, Croce M, Gore D et al. Prospective randomized controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med 2002; 165: 781-787.
50. Mitchell JP, Schuller D, Calandrino FS, Schuster DP. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 1992; 145: 990-998.
51. Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990; 97: 1176-1180.
52. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994; 124: 881-888.
53. Baldauf M, Silver P, Sagy M. Evaluating the validity of responsiveness to inhaled nitric oxide in pediatric patients with ARDS: an analytic tool. Chest 2001; 119: 1166-1172.
54. Willson DF, Zaritsky A, Bauman LA et al. Instillation of calf lung surfactant-extract is beneficial in pediatric acute hypoxemic fespiratory failure. Member of the Mid-Atlantic Pediatric Critical Care Network. Crit Care Med 1999; 27: 188-195.
55. Hermon MM, Golej J, Burda G et al. Surfactant therapy in infants and children: three years experience in a pediatric intensive care unit. Shock 2002; 17: 247-251.
56. Willson DF, Zaritsky A, Bauman LA et al. Instillation of calf lung surfactant extract (Calfactant) is beneficial in peidatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network. Crit Care Med 1999; 27: 188-195.
57. Luce JM, Montgornery AB, Marks JD, Turner J, Metz CA, Murrary JF. In effectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic stock. Am Rev Respir Dis 1988; 138: 62-68.
58. Bernard GR, Luce JM, Sprung CL et al. High dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317: 1565-1570.
59. Lefering R, Neugebauer EAM, Steroid controversy in sepsis and septic shock: a meta analysis: Crit Care Med 1995; 23: 1294-1303.
60. Cromnil L, Cock DJ, Carlet J et al. Cortico steroid treatment for sepsis; a critical appraisal and meta analysis of literature. Crit Care Med 1995; 23: 1430-1439.
61. Meduri GU, Headley SA, Golden E et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. JAMA 1998; 280: 159-165.
62. Mcintyre RC, Pulido EJ, Bensard DD, Shames BD, Abraham E. Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med 2000; 28: 3314-3331.
63. ARDS N. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network. JAMA 2000; 283: 1995-2002.
64. Payen DM, Gatecel C, Plaisance P. Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome. Lancet 1993; 341: 1664.
65. Fan J, Shek PN, Suntres ZE, Li YH, Oreopalgos GD, Rotstein OD. Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery 2000; 128: 332-338.
66. Bryan AC. Conference on the scientific basis of respiratory therapy pulmonary physiotherapy in the pediatric age group. Comments of a devil's advocate. Am Rev Respir Dis 1974; 110: 143-144.
67. Gattimoni L, Tognoni G, Pesenti A et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2004; 348: 568-573.
68. Numa AH, Hammer J, Neuth CJ. Effect of prone and supine position on functional residual capacity, oxygenation, and respiratory mechanics in ventilated infants and children. Am J Respir Crit Care Med 1997; 156: 1185-1189.
69. Murdoch IA, Storman MO. Improved arterial oxygenation in children with the adult respiratory distress syndrome: the prone position. Acta Paediatr 1994; 83: 1043-1046.
70. Komecki A, Frndova H, Coates AL, Shemie S. A randomized trial of prolonged prone positioning in children with acute respiratory failure. Chest 2001; 119: 211-218.
71. Green TP, Timmons OD, Fackler JC, Moler FN, Thompson AE, Sweeney ME. The impact of extra corporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure, Crit Care Med 1996; 24: 323-329.
72. Chang W, De Santi L, Denling RH. Anticatabolic and illness: a review of current treatment modalities. Shock 1998; 10: 155-160.
73. Monchi M, Bellenfant F, Carion A et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 1998; 158: 1076-1081.
74. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: Comorbid conditions, age, etiology and hospital outcome. Am J Respir Crit Care Med 1998; 157: 1159-1164.
75. Timmons OD, Dean JM, Vernon DD, Mortality rates and prognostic variables in children with adult respiratory distress syndrome. J Pediatr 1991; 119: 896-899.
76. Cronshaw J, Griffiths MJD, Evans TW. The pulmonary care 9 non-ventilatory strategies in ARDS. Thorax 2000; 57: 823-829.
77. Ben-Abraham R, Weinbroum AA, Roizini H et al. Long term assessment of pulmonary function tests in pediatric survivors of acute respiratory distress, syndrome. Med Sci Monit 2002; 8: 153-157.